Biogenic Silver Nanoparticles from Nothapodytes foetida Kills Human Cancer Cells In Vitro Through Inhibition of Cell Proliferation and Induction of Apoptosis

2017 ◽  
Vol 11 (5) ◽  
pp. 416-427 ◽  
Author(s):  
Kailas D. Datkhile ◽  
Pratik P. Durgavale ◽  
Madhavi N. Patil
2019 ◽  
Vol 71 (1) ◽  
pp. 165-180 ◽  
Author(s):  
Tomasz Kowalczyk ◽  
Przemysław Sitarek ◽  
Ewa Skała ◽  
Monika Toma ◽  
Marzena Wielanek ◽  
...  

2013 ◽  
Vol 27 (11) ◽  
pp. 1664-1670 ◽  
Author(s):  
Ramar Thangam ◽  
Veeraperumal Suresh ◽  
Mayan Rajkumar ◽  
Jally Damien Vincent ◽  
Palani Gunasekaran ◽  
...  

2012 ◽  
Vol 1 (2) ◽  
pp. 51 ◽  
Author(s):  
Etienne Mfoumou ◽  
Sivakumar Narayanswamy ◽  
Ion Stiharu ◽  
Ala-Eddin Al Moustafa

Materials ◽  
2021 ◽  
Vol 14 (3) ◽  
pp. 534
Author(s):  
Jeroni Morey ◽  
Pere Llinás ◽  
Alberto Bueno-Costa ◽  
Alberto J. León ◽  
M. Nieves Piña

Two different raltitrexed gold and silver nanoparticles for the delivery of an antitumoral drug into cancer cells were synthesized and characterized. A cysteine linker was used for the covalent bonding of raltitrexed to the surface of nanoparticles. To evaluate the efficacy of the antifolate-derivative nanoparticles, their cytotoxicity was assayed in vitro with A549 human lung adenocarcinoma and HCT-116 colorectal carcinoma human cells. Modified nanoparticles are a biocompatible material, and administration of silver raltitrexed nanoparticles strongly inhibited the viability of the cancer cells; gold raltitrexed nanoparticles do not show any type of cytotoxic effect. The results suggest that silver raltitrexed nanoparticles could be a potential delivery system for certain cancer cells.


2021 ◽  
Vol 22 (16) ◽  
pp. 8372
Author(s):  
Ana María Zárate ◽  
Christian Espinosa-Bustos ◽  
Simón Guerrero ◽  
Angélica Fierro ◽  
Felipe Oyarzún-Ampuero ◽  
...  

The Smoothened (SMO) receptor is the most druggable target in the Hedgehog (HH) pathway for anticancer compounds. However, SMO antagonists such as vismodegib rapidly develop drug resistance. In this study, new SMO antagonists having the versatile purine ring as a scaffold were designed, synthesised, and biologically tested to provide an insight to their mechanism of action. Compound 4s was the most active and the best inhibitor of cell growth and selectively cytotoxic to cancer cells. 4s induced cell cycle arrest, apoptosis, a reduction in colony formation and downregulation of PTCH and GLI1 expression. BODIPY-cyclopamine displacement assays confirmed 4s is a SMO antagonist. In vivo, 4s strongly inhibited tumour relapse and metastasis of melanoma cells in mice. In vitro, 4s was more efficient than vismodegib to induce apoptosis in human cancer cells and that might be attributed to its dual ability to function as a SMO antagonist and apoptosis inducer.


2021 ◽  
Vol 45 (11) ◽  
pp. 5176-5183
Author(s):  
Ichraf Slimani ◽  
Serap Şahin-Bölükbaşı ◽  
Mustafa Ulu ◽  
Enes Evren ◽  
Nevin Gürbüz ◽  
...  

A series of benzimidazolium salts and their [RhCl(NHC)(COD)] complexes were synthesized. All compounds were screened for in vitro cytotoxic activities against a panel of human cancer cells (HT-29 colon, Ishikawa endometrial, U-87 glioblastoma) using the MTT assay for 48 h incubation time.


Sign in / Sign up

Export Citation Format

Share Document